WQ90384 (e) Wedi’i gyflwyno ar 10/01/2024

Beth mae Llywodraeth Cymru yn ei wneud i fynd i'r afael â'r prinder therapi amnewid hormonau, sy'n ffurfio bron i hanner y protocolau prinder difrifol a gyhoeddwyd yn ôl The Pharmaceutical Journal?

Wedi'i ateb gan Y Gweinidog Iechyd a Gwasanaethau Cymdeithasol | Wedi'i ateb ar 17/01/2024

I set out the extensive measures taken by the Welsh and UK Governments to support pharmacists, prescribers and patients to manage shortages in my written statement on this matter, published on 18 October. The statement can be accessed at: https://www.gov.wales/written-statement-disruptions-supply-medicines

Maintaining the continuity of supply of medicines to the UK is a reserved matter and is the responsibility of the UK Government. However, managing the implications of supply disruptions for patients and the NHS requires co-ordinated action between the UK and devolved governments, and the NHS. 

Welsh Government officials work closely with their counterparts in the UK Government, manufacturers, wholesalers, prescribers and pharmacies to mitigate the effect of any disruption.